Curetis N.V. Informs on OpGen´s Fourth Quarter and Full Year 2019 Financial Results and Business Update
(WorldNews Netherlands)

Curetis N.V. Informs on OpGen`s Fourth Quarter and Full Year 2019 Financial Results and Business Update Quorum achieved for OpGen stockholder vote on Curetis business combination with 99% of votes supporting transaction Transaction close anticipated by early April 2020 Combined OpGen and Curetis business generated $6 million in unaudited pro forma combined 2019 revenue (up from $4.5 million in 2018) First shipments of BGISARS-CoV-2 rapid PCR kits completed by Curetis in Europe. Additional actions planned to address the global COVID-19 pandemic Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, March 25, 2020, 08:00 am CET- Curetis N.V. (the "Company" and...